Overview
- IQVIA tracked 3,071 U.S. prescriptions for the Wegovy pill in its first launch week, with analysts noting the tally excludes some online channels, and Symphony data estimated about 4,290 in the first full week.
- The U.K. MHRA approved a 7.2 mg weekly Wegovy regimen for adults with a BMI of 30 or higher, given as three 2.4 mg injections on the same day, following data showing roughly 21% average weight loss versus the 2.4 mg dose.
- Clinical studies report the daily oral semaglutide produced average weight loss around 16–17% and the pill is stocked at 70,000+ U.S. pharmacies and via telehealth, including nationwide delivery through Amazon Pharmacy.
- Out-of-pocket costs can drop to about $25 per month with commercial insurance and manufacturer coupons, while uninsured patients may pay roughly $149–$299 depending on dose and pharmacy.
- Clinicians emphasize strict empty-stomach dosing for the pill and monitoring for gastrointestinal side effects, and they caution against unregulated compounded versions that lack FDA approval and consistent quality.